USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
USANA Health Sciences, Inc. (USNA) filed a Current Report on Form 8-K on October 9, 2025. The filing announces preliminary financial results for the third quarter ended September 27, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that preliminary results were issued via a press release but does not contain the numerical data within the 8-K body itself.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It references a press release (Exhibit 99.1) for the full details of the third-quarter performance.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. It explicitly states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review the press release attached as Exhibit 99.1 for specific Q3 2025 revenue and earnings figures.
- Verify the exact date of the quarter end (September 27, 2025) when comparing to prior periods.
- Check for any subsequent filings or updates regarding the preliminary nature of the results.
- Confirm if the press release includes updated full-year guidance or outlook.